CR6835A - Un paquete combinado usado en el tratamiento de la malaria - Google Patents

Un paquete combinado usado en el tratamiento de la malaria

Info

Publication number
CR6835A
CR6835A CR6835A CR6835A CR6835A CR 6835 A CR6835 A CR 6835A CR 6835 A CR6835 A CR 6835A CR 6835 A CR6835 A CR 6835A CR 6835 A CR6835 A CR 6835A
Authority
CR
Costa Rica
Prior art keywords
malaria
treatment
pack used
amino
combined pack
Prior art date
Application number
CR6835A
Other languages
English (en)
Inventor
Francis Pinto Joseph
Swati Piramal Ajay
Pratap Ram
Amiya Bhaduri Prassad
Harsh Thapliyal Pati
Sumil Puri Kumar
Singh Satayawan
Srivastava Pratima
Vikash Pandey Chandra
Srivastava Sudhir
Shio Singh Kumar
Ram Gupta Chandra
Jagdishwar Srivastava Sahai
Omkar Asthana Prassad
Original Assignee
Nicholas Piramal India Ltd
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd, Council Scient Ind Res filed Critical Nicholas Piramal India Ltd
Publication of CR6835A publication Critical patent/CR6835A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Un estuche de combinacion para el tratamiento del paludismo producido por Plasmodium vivax (P. vivax), que tiene dosis individuales de un agente antipaludico, 3 -[1-[[4-[(6-metoxi-8-quinolinil)amino]pentil]amino]etilideno]-dihidro-2-(3H) furanona (I) en forma de capsulas; dosis individuales del agente antipaludico cloroquina en forma de comprimidos; y material de instrucciones para la administracion de los dos farmacos antipaludicos.
CR6835A 2000-05-31 2002-11-28 Un paquete combinado usado en el tratamiento de la malaria CR6835A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN501MU2000 2000-05-31

Publications (1)

Publication Number Publication Date
CR6835A true CR6835A (es) 2007-04-26

Family

ID=11097250

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6835A CR6835A (es) 2000-05-31 2002-11-28 Un paquete combinado usado en el tratamiento de la malaria

Country Status (28)

Country Link
US (1) US7404962B1 (es)
EP (1) EP1292306B1 (es)
JP (1) JP2004505017A (es)
KR (1) KR20030025926A (es)
AP (1) AP1435A (es)
AR (1) AR028458A1 (es)
AT (1) ATE314848T1 (es)
AU (2) AU2001228790B2 (es)
BR (1) BR0005247A (es)
CA (1) CA2413775C (es)
CR (1) CR6835A (es)
CZ (1) CZ296875B6 (es)
DE (2) DE00993875T1 (es)
DK (1) DK1292306T3 (es)
EC (1) ECSP003694A (es)
ES (1) ES2200729T3 (es)
GT (1) GT200000187A (es)
HK (1) HK1052467B (es)
HN (1) HN2001000118A (es)
HU (1) HUP0301925A3 (es)
MX (1) MXPA02011883A (es)
NO (1) NO324774B1 (es)
OA (1) OA12276A (es)
PE (1) PE20011319A1 (es)
PL (1) PL200748B1 (es)
SV (1) SV2002000201A (es)
WO (1) WO2001091535A2 (es)
ZA (1) ZA200209726B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114892B2 (en) * 2006-02-16 2012-02-14 The Mclean Hospital Corporation Methods and compositions for the treatment of Parkinson's Disease
WO2010065932A1 (en) * 2008-12-05 2010-06-10 Designmedix, Inc. Modified chloroquines with single ring moiety or fused ring moiety
WO2010144102A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command Pentafluorosulfanyl analogs of mefloquine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5270037A (en) * 1990-07-12 1993-12-14 Boehringer Ingelheim Gmbh Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
JP3560970B2 (ja) * 1992-02-07 2004-09-02 ノバルティス アクチェンゲゼルシャフト ベンゾフルメトールを含有する抗マラリア性の相乗作用組成物

Also Published As

Publication number Publication date
AU2879001A (en) 2001-12-11
WO2001091535A3 (en) 2002-07-04
HN2001000118A (es) 2001-10-29
AU2001228790B2 (en) 2007-02-01
AP2002002672A0 (en) 2002-12-31
PE20011319A1 (es) 2002-03-02
HUP0301925A3 (en) 2009-03-30
ES2200729T1 (es) 2004-03-16
MXPA02011883A (es) 2004-05-17
HK1052467A1 (en) 2003-09-19
JP2004505017A (ja) 2004-02-19
HUP0301925A2 (hu) 2003-09-29
DE60025403D1 (de) 2006-03-30
DK1292306T3 (da) 2006-05-22
NO324774B1 (no) 2007-12-10
NO20025765D0 (no) 2002-11-29
WO2001091535B1 (en) 2002-10-31
DE00993875T1 (de) 2004-04-15
AR028458A1 (es) 2003-05-07
AP1435A (en) 2005-06-21
PL200748B1 (pl) 2009-02-27
EP1292306B1 (en) 2006-01-04
ES2200729T3 (es) 2006-07-16
ZA200209726B (en) 2004-03-10
HK1052467B (zh) 2006-03-10
CA2413775C (en) 2009-08-25
GT200000187A (es) 2002-04-18
DE60025403T2 (de) 2006-08-24
SV2002000201A (es) 2002-10-24
NO20025765L (no) 2003-01-08
PL372718A1 (en) 2005-07-25
BR0005247A (pt) 2002-02-13
WO2001091535A2 (en) 2001-12-06
CZ20024071A3 (cs) 2003-04-16
OA12276A (en) 2006-05-10
KR20030025926A (ko) 2003-03-29
US7404962B1 (en) 2008-07-29
ATE314848T1 (de) 2006-02-15
EP1292306A2 (en) 2003-03-19
ECSP003694A (es) 2002-01-25
CA2413775A1 (en) 2001-12-06
CZ296875B6 (cs) 2006-07-12

Similar Documents

Publication Publication Date Title
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
CO5190672A1 (es) Composicion para la dosificacion oral, de disolucion instantanea
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
HUP0302857A2 (hu) Gyógyszerészeti kiszerelés
ITMI20041317A1 (it) Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
CY1105211T1 (el) Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη
TW200609005A (en) Film-coated tablet with plural coating-layers
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
CY1106741T1 (el) Επικαλυμμενα μινι-δισκια παρατεταμενης αποδεσμευσης υδροχλωρικης βενλαφαξινης
ATE292453T1 (de) Antivirale arznei
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
AR032642A1 (es) Composiciones quimioterapicas de paclitaxel en microemulsion con mayor biodisponibilidad oral.
ATE442158T1 (de) Oral verabreichte pharmazeutische zusammensetzungen mit einem abgabemittel in mikronisierter form
CR6835A (es) Un paquete combinado usado en el tratamiento de la malaria
AR036877A1 (es) Formulacion farmaceutica
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
CO5271706A1 (es) Unidad de dosis de mirtazapina para el tratamiento de transtornos del sueno
DE60111503D1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
AR023452A1 (es) Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor
DK1476160T3 (da) Farmaceutisk sammensætning af artesunat og mefloquin til behandling af malaria
NO20050445L (no) Synergistisk interaksjon mellom abacavir og alovudin
ATE311883T1 (de) Stabile pharmazeutische anwendungsform für paroxetin-anhydrat

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)